Dr. Gallican Rwibasira
Division Manager | HIV, STI, Viral Hepatitis and Other Viral Diseases Control Division
Email : gallican.rwibasira@rbc.gov.rw
Email : gallican.rwibasira@rbc.gov.rw
The HIV, STI, Viral Hepatitis and Other Viral Diseases Control Division coordinates all activities to prevent HIV/AIDS, sexually transmitted infections (STIs) and viral hepatitis. The department has four units: HIV Prevention, HIV Care and Treatment Services, HIV Epidemiology Surveillance and Research (HESR) and Sexually Transmitted Infections (STIs) and Viral Hepatitis.
The division provides HIV prevention, testing, treatment, STI management, viral hepatitis control, and community outreach services.
All individuals can access HIV services, including high-risk populations such as sex workers, MSM, transgender people, and mobile populations.
PrEP (Pre-Exposure Prophylaxis) and PEP (Post-Exposure Prophylaxis) are medications used to prevent HIV infection before or after exposure.
You can get tested at health facilities, community testing sites, or use HIV self-testing kits available across Rwanda.
PMTCT stands for Prevention of Mother-to-Child Transmission and helps prevent HIV transmission from mothers to their babies.
~210,000 people are living with HIV in Rwanda.
This represents a national prevalence of approximately 3.0% among adults.
The overall HIV prevalence among adults is about 2%–3%.
Women are more affected than men, with higher prevalence rates.
Rwanda has reduced new HIV infections by over 80% in recent decades.
AIDS-related deaths have also significantly declined.
Rwanda is among the few countries to achieve the UNAIDS targets:
Over 95% of HIV-positive pregnant women receive treatment.
This supports elimination of mother-to-child transmission.
More than 94%+ of people living with HIV are on ART.
High retention rates ensure long-term treatment success.
People living with HIV who know their status.
Diagnosed individuals receiving ART.
People on treatment with viral suppression.